作者单位:
Rheumatology and Rare Disease Research Center, The Wohl Institute for Translational Medicine, Hadassah-Hebrew University Medical Center and School, Jerusalem, Israel.
[1]
Intensive Care Unit, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
[2]
Department of Cardiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
[3]
Enlivex Therapeutics Ltd., Ness-Ziona, Israel.
[4]
Rheumatology and Rare Disease Research Center, The Wohl Institute for Translational Medicine, Hadassah-Hebrew University Medical Center and School, Jerusalem, Israel. mevorachd@hadassah.org.il.
[5]
Department of Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. mevorachd@hadassah.org.il.
[6]
DOI
10.1038/s41419-020-02748-8
PMID
32669536
发布时间
2024-03-29